Maravai Lifesciences Holdings (MAR) Ownership - Who Owns Maravai Lifesciences Holdings?
Maravai Lifesciences Holdings (MAR) Ownership Overview
- 3.29% Insiders
- 18.16% Mutual Funds
- 0.13% Other Institutional Investors
- 11.71% ETFs
- 66.71% Public Companies and Individual Investors
The ownership structure of Maravai Lifesciences Holdings (DE:MAR) stock is a mix of institutional, retail, and individual investors. Approximately 30.00% of the company’s stock is owned by Institutional Investors, 3.29% is owned by Insiders, and 66.71% is owned by Public Companies and Individual Investors.
The ownership structure of Maravai Lifesciences Holdings (DE:MAR) stock is a mix of institutional, retail, and individual investors. Approximately 30.00% of the company’s stock is owned by Institutional Investors, 3.29% is owned by Insiders, and 66.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 08, 2025 | Gregory Lucier | $368,544 | |
| Nov 16, 2025 | Bernd Brust | $702,689 | |
| Nov 12, 2025 | Bernd Brust | $809,010 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Royce & Associates Llc | €5,544,984 | |
| Dec 31, 2025 | First Eagle Investment Management Llc | €5,847,842 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 6,502,737 | Institution | 4.36% | 49,908,506 |
| Ishares | 5,563,514 | Institution | 3.73% | 42,699,970 |
| Vanguard Index Funds | 5,161,527 | Institution | 3.46% | 39,614,720 |
| Jean Marie Eveillard | 3,671,287 | Institution | 2.46% | 28,177,128 |
| First Eagle Funds | 3,242,395 | Institution | 2.18% | 24,885,382 |
| Tiaa-cref Funds | 2,380,775 | Institution | 1.60% | 18,272,448 |
| Bernd Brust | 2,028,020 | Insider | 1.36% | 15,565,054 |
| Fidelity Securities Fund | 1,923,890 | Institution | 1.29% | 14,765,856 |
| Chuck Royce | 1,808,448 | Institution | 1.21% | 13,879,838 |
| Columbia Funds Series Trust I | 1,699,070 | Institution | 1.14% | 13,040,362 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 5,161,527 | Institution | 3.46% | 39,614,720 |
| First Eagle Funds | 3,242,395 | Institution | 2.18% | 24,885,382 |
| Tiaa-cref Funds | 2,380,775 | Institution | 1.60% | 18,272,448 |
| Fidelity Securities Fund | 1,923,890 | Institution | 1.29% | 14,765,856 |
| Columbia Funds Series Trust I | 1,699,070 | Institution | 1.14% | 13,040,362 |
| Fidelity Salem Street Trust | 1,410,564 | Institution | 0.95% | 10,826,079 |
| Meridian Fund Inc | 1,275,000 | Institution | 0.86% | 9,785,625 |
| Fidelity Concord Street Trust | 1,219,669 | Institution | 0.82% | 9,360,960 |
| Columbia Funds Series Trust I | 1,147,783 | Institution | 0.77% | 8,809,235 |
| Vanguard Scottsdale Funds | 761,717 | Institution | 0.51% | 5,846,178 |
FAQ
Who Owns Maravai Lifesciences Holdings (DE:MAR)?
According to the latest TipRanks data, approximately 30.00% of the company's stock is held by institutional investors, 3.29% is held by insiders, and 66.71% is held by public companies and individual investors.
What percentage of Maravai Lifesciences Holdings (DE:MAR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.00% of Maravai Lifesciences Holdings (DE:MAR) stock is held by institutional investors: 18.16% by mutual funds, 11.71% by ETFs and 0.13% by other institutional investors.
What percentage of Maravai Lifesciences Holdings (DE:MAR) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.71% of Maravai Lifesciences Holdings (DE:MAR) stock is held by public companies and individual investors.
Who owns the most shares of Maravai Lifesciences Holdings (DE:MAR)?
Vanguard owns the most shares of Maravai Lifesciences Holdings (DE:MAR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.